AstraZeneca do Brasil is a biofarmaceutical company. AstraZeneca do Brasil focuses on developing drugs and therapies in the areas of cardiovascular, renal, metabolic, respiratory, and oncological diseases. The company's main activity is carried out mainly in three regions, and it aims to improve the lives of 5 million Brazilian patients by 2025. AstraZeneca do Brasil is dedicated to researching the mechanisms that cause diseases to develop treatments, with a focus on respiratory and immunology therapeutic areas. The company offers a portfolio of biological drugs targeting cells and immune pathways that play a role in the development of diseases such as asthma and chronic obstructive pulmonary disease (DPOC). AstraZeneca do Brasil is also focused on developing inhalational and biological therapies, combinations of medications, and unique devices to offer tailored treatments to the needs of patients.
Headquarters
Rodovia Raposo Tavares S/N, Km. 26.9, Granja Viana
Cotia; Sao Paulo;
Postal Code: 06707000
Contact Details: Purchase the Astrazeneca do Brasil Ltda. report to view the information.
Website: http://www.astrazeneca.com.br
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service